Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improved single-dose metyrapone test.

G Dickstein, D Barzilai

    Israel Journal of Medical Sciences
    |May 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    A single dose of metyrapone effectively assesses pituitary-adrenal reserve by measuring plasma ACTH and cortisol precursors. This simplified method offers accurate results with low toxicity, improving diagnostic efficiency.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Role of cytological and ultrasonographic features in predicting the risk of malignancy in thyroid nodules with indeterminate cytology.

    Minerva endocrinologica·2014
    Same author

    Hepatosplenic gamma/delta T-cell lymphoma masquerading as alcoholic hepatitis and methadone withdrawal.

    Case reports in gastroenterology·2011
    Same author

    The assessment of the hypothalamo-pituitary-adrenal axis in pituitary disease: are there short cuts?

    Journal of endocrinological investigation·2003
    Same author

    [Does hypothyroidism contribute to the etiology of primary open angle glaucoma or is it just a coincidence?].

    Harefuah·2003
    Same author

    CRH test and ACTH test--what is the difference?

    The Israel Medical Association journal : IMAJ·2003
    Same author

    Atopic dermatitis management: comparing the treatment patterns of dermatologists in Japan, U.S.A. and U.K.

    The British journal of dermatology·2002
    Same journal

    Coronary revascularization versus conservative medical management for preoperative optimization of a patients with documented ischemic heart disease.

    Israel journal of medical sciences·1998
    Same journal

    Primary biliary cirrhosis--association or overlap with other autoimmune diseases.

    Israel journal of medical sciences·1998
    Same journal

    Complementary medicine--the problem and the challenge.

    Israel journal of medical sciences·1998
    Same journal

    Electroencephalography in the evaluation of headache patients: a review.

    Israel journal of medical sciences·1998
    Same journal

    Complementary medicine--a critical review.

    Israel journal of medical sciences·1998
    Same journal

    The Israel Longitudinal Mortality Study--differential mortality in Israel 1983-1992: objectives, materials, methods and preliminary results.

    Israel journal of medical sciences·1998
    See all related articles

    Area of Science:

    • Endocrinology
    • Pharmacology
    • Clinical Diagnostics

    Background:

    • Assessing pituitary-adrenal reserve is crucial for diagnosing endocrine disorders.
    • Traditional methods for evaluating pituitary-adrenal function often involve multiple drug administrations over extended periods.
    • There is a need for simpler, safer, and more efficient diagnostic protocols.

    Purpose of the Study:

    • To evaluate the efficacy of a single-dose metyrapone test for assessing pituitary-adrenal reserve.
    • To determine optimal timing for measuring key biomarkers after metyrapone administration.
    • To establish a simplified protocol with reduced toxicity and improved patient compliance.

    Main Methods:

    • Administered a single oral dose of metyrapone (1.5 g) at 6 AM to 18 subjects with normal pituitary-adrenal reserve.

    Related Experiment Videos

  • Measured plasma ACTH, 11-deoxycortisol, and 17-hydroxycorticosteroids (17-OHCS) at noon and 2 PM.
  • Compared pre- and post-metyrapone biomarker levels to assess pituitary-adrenal response.

    • Main Results:

    • Significant increases in plasma ACTH, 11-deoxycortisol, and 17-OHCS were observed post-metyrapone administration (P < 0.001).
    • Biomarker levels showed no overlap between pre- and post-metyrapone measurements, indicating clear diagnostic separation.
    • The protocol demonstrated accurate assessment of pituitary-adrenal reserve 6-8 hours after a single metyrapone dose.

    Conclusions:

    • A single 1.5 g dose of metyrapone administered in the morning allows accurate assessment of pituitary-adrenal reserve.
    • Measuring plasma ACTH, 11-deoxycortisol, or 17-OHCS at noon and 2 PM provides reliable diagnostic information.
    • This simplified protocol offers advantages of low dose, low toxicity, and eliminates the need for prolonged testing.